Concomitant Use of Niacin and Statins and Concomitant Use of Fenofibrates and Statins

Project Title Concomitant Use of Niacin and Statins and Concomitant Use of Fenofibrates and Statins
Date Posted
Friday, June 3, 2016
Status
Complete
Related Links
Niacin and Niacin Combination Products, Fenofibrates, and Omega-3 Products
Safety Assessment of Niacin in the U.S. Food and Drug Administration's Mini-Sentinel System
Niacin and Fenofibrate Use and Outcomes with Propensity Score Matching
Description

Modular program-based one-time assessment of concomitant use of niacin and statins and concomitant use of fenofibrates and statins. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2000 to May 31, 2013.  Modular programs are adaptable standardized programs. Results were generated using Modular Program 4; click here for more information.  Queries were distributed in March 2014. 
 
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.
 
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
fenofibrate
niacin
statin
Time Period
January 1, 2000 - May 31,2013
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER
Scroll to Top